1. 14 Phase II trial evaluating efficacy and safety of standard of care with or without bevacizumab in platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer. (13th November 2020) Authors: Nishikawa, N; Shoji, T; Enomoto, T; Abe, M; Okamoto, A; Saito, T; Oishi, T; Nagase, S; Mori, M; Inokuchi, Y; Kamiura, SK; Sugiyama, T Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗